Cardlytics Proceeds Revenue Tightening In The Middle Of Deteriorating Economics (NASDAQ: CDLX)

.Financial writer suggests selling Cardlytics, Inc. because of dropping device economics, revenue challenges, and negative monetary styles. Click for this CDLX update.